Replimune Group, Inc.

NASDAQ:REPL

Annual Meeting

of Shareholders

MEETING DATE

09/15/2026

DEF 14A FILED

07/28/2026

PUBLISHED

07/28/2026 10:14 pm

TIME TO PUBLISH

07/30/2026

METHODOLOGY

approve

EXCHANGE NASDAQ:REPL · CUSIP 76029N106 · CLASS common stock · CIK 0001737953

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

FOR

AGAINST

WITHHOLD

BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

Ratification of selection of independent registered public accounting firm

auditor
Routine

For

Board FOR · Duopoly unknown — No divergence flagged

− RATIONALE

The Audit Committee annually reviews the independent registered public accounting firm's independence and performance.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers

compensation
Routine

For

Board FOR · Duopoly unknown — No divergence flagged

− RATIONALE

The filing states compensation is designed to attract, retain, motivate and reward executives.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Approval of an amendment to the Third Amended and Restated Certificate of Incorporation of the Company to increase the number of authorized shares of common stock, par value $0.001 per share, from 150,000,000 shares to 300,000,000 shares

other
Routine

For

Board FOR · Duopoly unknown — No divergence flagged

− RATIONALE

Only 30,258,728 authorized common shares remained available for future issuance as of March 31, 2026.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

659c4eb85a0538fd863d97ffbe853b9fddeb3e21921f6f3284bc6e9d91e6972c

Replimune Group, Inc.

Ledger

Get every ballot call, before the vote.

Submit Information

Join Monitoring List

Receive Research Updates